Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Current Leases (2019 - 2025)

STRATA Skin Sciences' Current Leases history spans 7 years, with the latest figure at $266000.0 for Q3 2025.

  • For Q3 2025, Current Leases fell 17.39% year-over-year to $266000.0; the TTM value through Sep 2025 reached $266000.0, down 17.39%, while the annual FY2024 figure was $328000.0, 6.82% down from the prior year.
  • Current Leases for Q3 2025 was $266000.0 at STRATA Skin Sciences, down from $303000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $404000.0 in Q3 2023 and bottomed at $224000.0 in Q2 2022.
  • The 5-year median for Current Leases is $328000.0 (2024), against an average of $328473.7.
  • The largest annual shift saw Current Leases crashed 41.51% in 2022 before it surged 75.0% in 2023.
  • A 5-year view of Current Leases shows it stood at $318000.0 in 2021, then increased by 11.64% to $355000.0 in 2022, then dropped by 0.85% to $352000.0 in 2023, then dropped by 6.82% to $328000.0 in 2024, then fell by 18.9% to $266000.0 in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Current Leases are $266000.0 (Q3 2025), $303000.0 (Q2 2025), and $331000.0 (Q1 2025).